|14th October 2020||Michelle Renee Griffin||7,351||Open or private sale||$53.07||$390,117.57|
|14th October 2020||Michelle Renee Griffin||12,000||Exercise of derivative||$7.80||$93,600.00|
|14th October 2020||Michelle Renee Griffin||4,649||Open or private sale||$52.48||$243,979.52|
|30th September 2020||Byron Lawson||350||Payment by withholding||$0.33||$115.50|
|30th September 2020||Tim B Johnson||1,630||Payment by withholding||$0.33||$537.90|
|30th September 2020||Shaun D Mc Means||461||Payment by withholding||$0.33||$152.13|
|30th September 2020||John L Lubniewski||921||Payment by withholding||$0.33||$303.93|
|30th June 2020||Tim B Johnson||1,630||Payment by withholding||$0.72||$1,173.60|
|30th June 2020||Shaun D Mc Means||447||Payment by withholding||$0.72||$321.84|
|30th June 2020||Byron Lawson||350||Payment by withholding||$0.72||$252.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
HTG Molecular Diagnostics, Inc. provides molecular technology solutions that facilitates molecular profiling. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.